Physician

Bryan James Krull, DO

According to 2025 Medicare claims, Bryan Krull, DO (NPI: 1649296682) practices nephrology in the Brunswick-St. Simons, GA market, with the plurality of this provider's patient population coming from Glynn, GA. This provider's primary affiliated billing organization is NEPHROLOGY AND HYPERTENSION MEDICAL ASSOCIATES PC (NPI: 1356879902; TIN: 58-1052081) and primary practice location at 31520-4787. Krull is affiliated with the Pearl Primary Care Network, LLC (ACO ID: D0242), participating under the REACH model.

Krull's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 444 traditional Medicare patients, billed 1,869 HCPCS/CPT codes, and received $166,351 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,663 prescription claims across 372 beneficiaries totaling $483,144 in drug costs, led by Jardiance (Empagliflozin). DME data shows 67 claims. Open Payments data shows 65 records totaling $1,357. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $118,404 to $166,351. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $285,938 and ending at $483,144. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $5,704.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$95K$190K2015 Medicare payment: $118,404 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $119,536 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $125,588 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $111,441 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $190,096 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $189,397 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $189,865 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $178,073 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $163,240 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $166,351 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153211,661$118,404
20163702,033$119,536
20173221,687$125,588
20183971,204$111,441
20194092,076$190,096
20203981,924$189,397
20213891,866$189,865
20224381,895$178,073
20234231,545$163,240
20244441,869$166,351

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$268K$535K2015 Drug cost: $285,938 (USD; Tot_Drug_Cst)2016 Drug cost: $412,673 (USD; Tot_Drug_Cst)2017 Drug cost: $493,277 (USD; Tot_Drug_Cst)2018 Drug cost: $178,114 (USD; Tot_Drug_Cst)2019 Drug cost: $439,823 (USD; Tot_Drug_Cst)2020 Drug cost: $283,140 (USD; Tot_Drug_Cst)2021 Drug cost: $535,185 (USD; Tot_Drug_Cst)2022 Drug cost: $341,769 (USD; Tot_Drug_Cst)2023 Drug cost: $508,229 (USD; Tot_Drug_Cst)2024 Drug cost: $483,144 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151592,155$285,938
20161742,275$412,673
20171762,244$493,277
20181651,502$178,114
2019151689$439,823
20201681,080$283,140
20212171,640$535,185
20223102,742$341,769
20233353,354$508,229
20243723,663$483,144

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.3K$4.5K2015 Medicare payment: $2,806 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,523 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,514 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $995 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $425 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,595 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,097 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R37$2,806
2016N/R83$4,523
2017N/R59$2,514
2018N/R26$995
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R23$425
2023N/R37$2,595
2024N/R67$1,097

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more5656$99
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes52138$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more251493$90
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes109307$62
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's216373$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin713,720$71,220
FarxigaDapagliflozin Propanediol813,390$60,154
BiktarvyBictegrav/Emtricit/Tenofov Ala12360$46,117
OzempicSemaglutide481,698$45,691
MyrbetriqMirabegron411,695$30,952

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsNN/R14$365
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R24$276
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R14$245
J7517Mycophenolate mofetil, oral, 250 mgNN/R15$212

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.65$1,357Ardelyx, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Bryan James Krull, DO?

Tedicare shows public-source Medicare data for Bryan James Krull, DO (NPI 1649296682), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bryan James Krull, DO have ACO affiliation data?

Bryan James Krull, DO is shown with ACO affiliation data for Pearl Primary Care Network, LLC (REACH, ACO ID D0242).

What billing organization is linked to Bryan James Krull, DO?

Bryan James Krull, DO is linked to NEPHROLOGY AND HYPERTENSION MEDICAL ASSOCIATES PC (billing NPI 1356879902) in the available physician profile data.

Does Bryan James Krull, DO have Open Payments data?

Bryan James Krull, DO has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.